Financial Ratios ATON Deutsche Boerse AG
Stocks
3HB
FR0004153930
Advanced Medical Equipment & Technology
|
Delayed
Deutsche Boerse AG
02:01:09 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.007800 EUR | 0.00% |
|
-11.36% | +200.00% |
| 04-30 | Aton Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 04-29 | Aton Auditor Raises 'Going Concern' Doubt | CI |
| Fiscal Period: December | 2018 (EUR) | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
Return on Assets | -0.79 | -2.6 | -5.8 | -10.62 | -8.95 | |||
Return on Total Capital | -1 | -3.23 | -8.54 | -15.89 | -9.83 | |||
Return On Equity % | -0.96 | -5.73 | -679.52 | 319.88 | -128.34 | |||
Return on Common Equity | -0.96 | -5.73 | -679.52 | 168.61 | -232.37 | |||
Margin Analysis | ||||||||
Gross Profit Margin % | - | -13.51K | -38.74 | 61.4 | 66.87 | |||
SG&A Margin | - | 23.9K | 146.23 | 158.31 | 122.69 | |||
EBITDA Margin % | - | -37.33K | -184.47 | -191.46 | -130.26 | |||
EBITA Margin % | - | -37.85K | -197.09 | -221.82 | -130.41 | |||
EBIT Margin % | - | -37.85K | -197.09 | -224.43 | -132.83 | |||
Income From Continuing Operations Margin % | - | -36.15K | -4.93K | -179.48 | -151.74 | |||
Net Income Margin % | - | -36.15K | -4.93K | -179.32 | -145.54 | |||
Net Avail. For Common Margin % | - | -36.15K | -4.93K | -179.32 | -145.54 | |||
Normalized Net Income Margin | - | -22.95K | -2.21K | -169.42 | -88.73 | |||
Levered Free Cash Flow Margin | - | - | - | -502.16 | 38.09 | |||
Unlevered Free Cash Flow Margin | - | - | - | -476.1 | 44.52 | |||
Asset Turnover | ||||||||
Asset Turnover | - | 0 | 0.05 | 0.08 | 0.11 | |||
Fixed Assets Turnover | - | 0.08 | 23.7 | 0.16 | 0.19 | |||
Receivables Turnover (Average Receivables) | - | 0.03 | 2.44 | 1.49 | 2.58 | |||
Short Term Liquidity | ||||||||
Current Ratio | 1.21 | 9.53 | 1.33 | 0.46 | 0.43 | |||
Quick Ratio | 1.21 | 9.52 | 1.3 | 0.45 | 0.42 | |||
Operating Cash Flow to Current Liabilities | - | - | - | 0.17 | 0.14 | |||
Days Sales Outstanding (Average Receivables) | - | 10.71K | 149.47 | 246.19 | 141.36 | |||
Average Days Payable Outstanding | 464.78 | 594.78 | 305.17 | - | 338.33 | |||
Long Term Solvency | ||||||||
Total Debt/Equity | 10.29 | 21.87 | -69.18 | 394.66 | 1.29K | |||
Total Debt / Total Capital | 9.33 | 17.94 | -224.45 | 79.78 | 92.8 | |||
LT Debt/Equity | - | 21.87 | -69.1 | 198.73 | 691.93 | |||
Long-Term Debt / Total Capital | - | 17.94 | -224.2 | 40.17 | 49.79 | |||
Total Liabilities / Total Assets | 28.28 | 32.69 | 554.52 | 81.72 | 93.39 | |||
EBIT / Interest Expense | -5.69 | -10.43 | -5.66 | -5.38 | -12.91 | |||
EBITDA / Interest Expense | -5.36 | -10.29 | -5.3 | -3.14 | -8.43 | |||
(EBITDA - Capex) / Interest Expense | -5.36 | -10.29 | -5.3 | -5.03 | -12.13 | |||
Total Debt / EBITDA | -8.36 | -3.84 | -4.6 | -5.78 | -8.64 | |||
Net Debt / EBITDA | 4.91 | -2.82 | -4.6 | -5.68 | -7.85 | |||
Total Debt / (EBITDA - Capex) | -8.36 | -3.84 | -4.6 | -3.62 | -6 | |||
Net Debt / (EBITDA - Capex) | 4.91 | -2.82 | -4.6 | -3.55 | -5.45 | |||
Growth Over Prior Year | ||||||||
Total Revenues, 1 Yr. Growth % | - | - | 24.4K | 0.33 | 7.65 | |||
Gross Profit, 1 Yr. Growth % | 8.62 | -17.88 | -29.73 | -11.71 | 17.24 | |||
EBITDA, 1 Yr. Growth % | -62.16 | 401.06 | 21.12 | -15.06 | 47.43 | |||
EBITA, 1 Yr. Growth % | -61.12 | 378.65 | 27.63 | -5.29 | -11.41 | |||
EBIT, 1 Yr. Growth % | -61.12 | 378.65 | 27.63 | -34.6 | -36.28 | |||
Earnings From Cont. Operations, 1 Yr. Growth % | -78.83 | 714.89 | 3.24K | -86 | -8.98 | |||
Net Income, 1 Yr. Growth % | -78.83 | 714.89 | 3.24K | -86.01 | -12.62 | |||
Normalized Net Income, 1 Yr. Growth % | -67.66 | -292.96 | 2.26K | -79.37 | -43.62 | |||
Diluted EPS Before Extra, 1 Yr. Growth % | -81.1 | - | - | -92.39 | -40.75 | |||
Accounts Receivable, 1 Yr. Growth % | -14.77 | -92.14 | 4.49K | -71.74 | 82.87 | |||
Net Property, Plant and Equip., 1 Yr. Growth % | -25.75 | -1.35 | -41.15 | -7.01 | -3.56 | |||
Total Assets, 1 Yr. Growth % | 104.8 | 15.59 | -93.22 | -33.91 | -9.98 | |||
Tangible Book Value, 1 Yr. Growth % | 92.36 | 5.37 | -150.63 | -114.09 | -166.33 | |||
Common Equity, 1 Yr. Growth % | 92.36 | 8.5 | -145.79 | -137.72 | -95.32 | |||
Cash From Operations, 1 Yr. Growth % | - | - | - | -114.9 | -22.75 | |||
Capital Expenditures, 1 Yr. Growth % | - | - | - | 215.03 | -47.72 | |||
Levered Free Cash Flow, 1 Yr. Growth % | - | - | - | -166.95 | -108.16 | |||
Unlevered Free Cash Flow, 1 Yr. Growth % | - | - | - | -163.2 | -110.07 | |||
Compound Annual Growth Rate Over Two Years | ||||||||
Total Revenues, 2 Yr. CAGR % | - | 302.98 | - | 1.88K | 3.93 | |||
Gross Profit, 2 Yr. CAGR % | -32.81 | -5.55 | -24.03 | 33.78 | 1.74 | |||
EBITDA, 2 Yr. CAGR % | -70.34 | 37.7 | 146.35 | 42.12 | -21.13 | |||
EBITA, 2 Yr. CAGR % | -69.9 | 36.42 | 147.16 | 51.92 | -22.58 | |||
EBIT, 2 Yr. CAGR % | -69.9 | 36.42 | 147.16 | 52.81 | -35.45 | |||
Earnings From Cont. Operations, 2 Yr. CAGR % | -69.34 | 31.34 | 1.55K | 39.84 | -64.3 | |||
Net Income, 2 Yr. CAGR % | -69.34 | 31.34 | 1.55K | 39.77 | -65.04 | |||
Normalized Net Income, 2 Yr. CAGR % | -75.63 | 42.68 | 574.85 | 70.52 | -65.9 | |||
Diluted EPS Before Extra, 2 Yr. CAGR % | -71.03 | - | 1.26K | - | -78.76 | |||
Accounts Receivable, 2 Yr. CAGR % | -4.8 | -74.11 | 89.94 | 422.13 | -28.31 | |||
Net Property, Plant and Equip., 2 Yr. CAGR % | -24.79 | -14.41 | -23.8 | 1.23K | -5.3 | |||
Total Assets, 2 Yr. CAGR % | 49.15 | 53.86 | -72 | -34.86 | -22.87 | |||
Tangible Book Value, 2 Yr. CAGR % | 34.29 | 42.36 | -26.96 | -80.14 | -69.43 | |||
Common Equity, 2 Yr. CAGR % | 34.29 | 44.47 | -29.51 | -72.2 | -86.72 | |||
Cash From Operations, 2 Yr. CAGR % | - | - | - | - | -66.07 | |||
Capital Expenditures, 2 Yr. CAGR % | - | - | - | - | 28.34 | |||
Levered Free Cash Flow, 2 Yr. CAGR % | - | - | - | - | -76.62 | |||
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | - | - | - | -74.78 | |||
Compound Annual Growth Rate Over Three Years | ||||||||
Total Revenues, 3 Yr. CAGR % | - | -81.21 | 1.48K | - | 651.09 | |||
Gross Profit, 3 Yr. CAGR % | -64.42 | -28.16 | -14.42 | 13.7 | 28.02 | |||
EBITDA, 3 Yr. CAGR % | -74.98 | -23.9 | 31.94 | 116.3 | 13.94 | |||
EBITA, 3 Yr. CAGR % | -74.55 | -24.3 | 33.42 | 122.71 | 13.46 | |||
EBIT, 3 Yr. CAGR % | -74.55 | -24.3 | 33.42 | 123.58 | 14.16 | |||
Earnings From Cont. Operations, 3 Yr. CAGR % | -79.06 | -8.49 | 286.4 | 151.64 | 21.19 | |||
Net Income, 3 Yr. CAGR % | -79.06 | -8.49 | 286.4 | 151.56 | 19.51 | |||
Normalized Net Income, 3 Yr. CAGR % | -77.19 | -27.97 | 263.54 | 77.69 | 17.91 | |||
Diluted EPS Before Extra, 3 Yr. CAGR % | - | - | 227.76 | 96.4 | - | |||
Accounts Receivable, 3 Yr. CAGR % | 4.27 | -58.54 | 45.42 | 28.94 | 267.37 | |||
Net Property, Plant and Equip., 3 Yr. CAGR % | -24.84 | -17.67 | -24.46 | 458.94 | 454.73 | |||
Total Assets, 3 Yr. CAGR % | 48.76 | 37 | -45.65 | -21.13 | -27.44 | |||
Tangible Book Value, 3 Yr. CAGR % | 94.5 | 23.86 | 0.87 | -65.36 | -70.31 | |||
Common Equity, 3 Yr. CAGR % | 94.5 | 25.08 | -1.5 | -56.23 | -84.65 | |||
Compound Annual Growth Rate Over Five Years | ||||||||
Total Revenues, 5 Yr. CAGR % | - | - | 37.86 | 21.18 | 485.58 | |||
Gross Profit, 5 Yr. CAGR % | - | - | -51.81 | -7.87 | 13.36 | |||
EBITDA, 5 Yr. CAGR % | - | - | -37.54 | -2.3 | 22.91 | |||
EBITA, 5 Yr. CAGR % | - | - | -36.81 | 0.02 | 22.14 | |||
EBIT, 5 Yr. CAGR % | - | - | -36.81 | 0.26 | 22.59 | |||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | 20.14 | 8.42 | 25.15 | |||
Net Income, 5 Yr. CAGR % | - | - | 20.14 | 8.4 | 24.11 | |||
Normalized Net Income, 5 Yr. CAGR % | - | - | 12 | 1.68 | 27.26 | |||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | - | -8.66 | -3.24 | |||
Accounts Receivable, 5 Yr. CAGR % | - | - | 32.54 | 14.21 | 27.15 | |||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | -24.43 | 150.58 | 162.67 | |||
Total Assets, 5 Yr. CAGR % | - | - | -23.73 | 1.76 | -1.99 | |||
Tangible Book Value, 5 Yr. CAGR % | - | - | 31.46 | -40.44 | -44.42 | |||
Common Equity, 5 Yr. CAGR % | - | - | 29.6 | -31.46 | -62.37 |
- Stock Market
- Stocks
- ALTAO Stock
- 3HB Stock
- Financials ATON
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















